HLS · ASX

Healius Limited (ASX:HLS)

AU$1.32

 -0.025 (-1.866%)
ASX:Live
21/11/2024 04:10:42 PM
Recent Price downgrade Recent Earnings downgrade HALO Small HALO Ords HALO 200 +5
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

HLS Overview

HLS Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Very Weak

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Very Strong

Valuation

Value

Consensus

Momentum

Price

Very Strong

Earnings

Very Strong

Growth

Earnings

Neutral

Dividends

Very Strong

Quality

Capital Efficiency

Strong

Balance Sheet

Strong

About HLS

Website

Healius Limited

Telephone

61.2.9432.9400

Address

Level 22 161 Castlereagh Street Liberty Place Sydney, New South Wales (NSW) 2000

Description

Healius Ltd. engages in the provision of healthcare technology solutions. It operates through the following segments: Pathology, Imaging, and Other. The Pathology segment provides pathology services. The Imaging segment focuses on imaging services from stand-alone imaging sites, hospitals, and medical centers. The Other segment consists of corporate functions. The company was founded by Edmund Gregory Thomas Bateman in 1985 and is headquartered in St. Leonards, Australia.

HLS Price Chart

Key Stats

Market Cap

AU$951.23M

PE

0.00

EV/EBITDA

5.0

Dividends Overview

DIV Yield

.1%

Franking

100%

Ex Dividend Date (est.)

07-Sep-22

Market Data

52 weeks range

Low 1.08 - 1.86

Trade Value (12mth)

AU$980,060.00

1 week

0.37%

1 month

-21.87%

YTD

-19.28%

1 year

-21.1%

All time high

9.10

Key Fundamentals

EPS 3 yr Growth

-1358.10%

EBITDA Margin

19.90%

Operating Cashflow

$238m

Free Cash Flow Return

8.80%

ROIC

-23.70%

Interest Coverage

4.90

Quick Ratio

0.40

Other Data

Shares on Issue (Fully Dilluted)

726m

HALO Sector

Healthcare

Next Company Report Date

20-Aug-25

Ex Dividend Date (est.)

07-Sep-22

Next Dividend Pay Date (est.)

21-Sep-22

Reporting Currency

AUD

Short Sell (% of issue)

2.33

HLS Announcements

Latest Announcements

Date Announcements

20 November 24

Change in substantial holding

×

Change in substantial holding

18 November 24

Becoming a substantial holder

×

Becoming a substantial holder

15 November 24

Chair's Address to Shareholders

×

Chair's Address to Shareholders

15 November 24

CEO Address to Shareholders

×

CEO Address to Shareholders

15 November 24

HLS 2024 AGM Results of Meeting

×

HLS 2024 AGM Results of Meeting

15 November 24

Amended Constitution of Healius Limited

×

Amended Constitution of Healius Limited

15 October 24

Notice of Annual General Meeting/Proxy Form

×

Notice of Annual General Meeting/Proxy Form

15 October 24

2024 HLS AGM Letter to Shareholders

×

2024 HLS AGM Letter to Shareholders

04 October 24

Becoming a substantial holder

×

Becoming a substantial holder

03 October 24

Notification of cessation of securities - HLS

×

Notification of cessation of securities - HLS

02 October 24

Ceasing to be a substantial holder

×

Ceasing to be a substantial holder

23 September 24

Sale of Lumus Imaging to Affinity Equity Partners

×

Sale of Lumus Imaging to Affinity Equity Partners

23 September 24

Lumus Imaging Sale Presentation

×

Lumus Imaging Sale Presentation

23 September 24

Investor Call Details - Sale of Lumus Imaging

×

Investor Call Details - Sale of Lumus Imaging

19 September 24

2024 Healius Annual Report

×

2024 Healius Annual Report

19 September 24

Appendix 4G

×

Appendix 4G

19 September 24

2024 Healius Corporate Governance Statement

×

2024 Healius Corporate Governance Statement

19 September 24

2024 Annual General Meeting Information

×

2024 Annual General Meeting Information

19 September 24

Becoming a substantial holder

×

Becoming a substantial holder

18 September 24

Change in substantial holding from PPT

×

Change in substantial holding from PPT

12 September 24

Ceasing to be a substantial holder

×

Ceasing to be a substantial holder

05 September 24

Ceasing to be a substantial holder

×

Ceasing to be a substantial holder

03 September 24

Application for quotation of securities - HLS

×

Application for quotation of securities - HLS

30 August 24

Change of Director's Interest Notice

×

Change of Director's Interest Notice

30 August 24

Change of Director's Interest Notice

×

Change of Director's Interest Notice

HLS Fundamentals

Per Share Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock 0.46 -0.61 -0.98 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock 0.46 -0.61 -0.98 Lock Lock Lock
     Growth % Lock Lock Lock Lock 494.1 -231.7 -60.9 Lock Lock Lock
     PE X Lock Lock Lock Lock 7.1 54.4 0.0 Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock 3.5 6.7 5.0 Lock Lock Lock
CFPS $ Lock Lock Lock Lock 1.00 0.51 0.39 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock 0.62 0.34 0.28 Lock Lock Lock
     Growth % Lock Lock Lock Lock 65.2 -48.9 -24.4 Lock Lock Lock
     Yield % Lock Lock Lock Lock 18.2 11.6 18.9 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.15 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock 20.8 -100.0 N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock 4.7 0.5 0.1 Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 32 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 3.12 2.45 1.43 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock -0.81 -0.75 -0.45 Lock Lock Lock
     Growth % Lock Lock Lock Lock -100.4 6.8 40.2 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 639 616 660 Lock Lock Lock
Basic m Lock Lock Lock Lock 630 616 660 Lock Lock Lock

Financial Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Income Statement
Sales $m Lock Lock Lock Lock 2,289 1,707 1,746 Lock Lock Lock
     Growth % Lock Lock Lock Lock 20.4 -25.4 2.3 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 305 244 265 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock 779 342 331 Lock Lock Lock
     Growth % Lock Lock Lock Lock 48.0 -56.1 -3.2 Lock Lock Lock
     Margin % Lock Lock Lock Lock 34.0 20.0 18.9 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 66 80 81 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock 745 375 347 Lock Lock Lock
     Growth % Lock Lock Lock Lock 48.3 -49.6 -7.6 Lock Lock Lock
     Margin % Lock Lock Lock Lock 32.6 22.0 19.9 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 271 277 281 Lock Lock Lock
EBIT $m Lock Lock Lock Lock 474 98 66 Lock Lock Lock
     Growth % Lock Lock Lock Lock 85.6 -79.3 -33.2 Lock Lock Lock
     Margin % Lock Lock Lock Lock 20.7 5.7 3.8 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock 415 -397 -650 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock 122 -17 -14 Lock Lock Lock
Net Income $m Lock Lock Lock Lock 291 -375 -646 Lock Lock Lock
     Growth % Lock Lock Lock Lock 460.4 -228.6 -72.4 Lock Lock Lock
     Margin % Lock Lock Lock Lock 12.7 -21.9 -37.0 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock 574 306 238 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 94 76 64 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock -402 67 -63 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock -164 -340 -230 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock 492 244 187 Lock Lock Lock
     Growth % Lock Lock Lock Lock 10.7 -50.5 -23.3 Lock Lock Lock
     Margin % Lock Lock Lock Lock 0.2 0.1 0.1 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock 194 178 161 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 81 115 60 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 4,137 3,651 2,983 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 1,555 1,503 1,327 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock 1,698 1,651 1,538 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 2,215 2,145 1,942 Lock Lock Lock
Equity $m Lock Lock Lock Lock 1,922 1,506 1,041 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 3,477 3,009 2,367 Lock Lock Lock
     Growth % Lock Lock Lock Lock 13.3 -13.5 -21.3 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock 7.0 -10.3 -21.7 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock 15.2 -24.9 -62.1 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock 13.6 2.8 2.2 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock 8.9 -11.7 -23.7 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock 17.5 9.4 8.8 Lock Lock Lock

Ratios Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Leverage
Interest Cover X Lock Lock Lock Lock 15.2 6.0 4.9 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 2.3 4.4 4.4 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock 88.3 109.6 147.8 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 0.6 0.5 0.5 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 0.5 0.5 0.4 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 21.9 33.7 20.0 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock 89.5 49.2 39.6 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 11.3 8.7 9.7 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 35.5 33.3 43.8 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 7.4 12.8 11.5 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.6 0.5 0.6 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.6 0.5 0.6 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock 18.1 -23.3 -37.2 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock 10.0 -10.9 -21.8 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock 29.5 0.0 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock 7.0 -10.3 -21.7 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 2.2 2.4 2.9 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock 15.2 -24.9 -62.1 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 68.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock 10.3 -24.9 -62.1 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 10.3 11.0 8.3 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 32.2 41.8 37.5 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 42.5 52.8 45.9 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 45.4 51.8 54.0 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock -2.9 1.0 -8.2 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

07-Sep-22

DIV Yield

.1%

Franking Level

100%

DPSg

N/A

Quality Yield

Lock

Falling Divs over next 2

Lock

Expected Dividend Cashflow

Dividend Clarity,
Enhanced
Strategy

Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

2.33%

Value ($M)

27

Prior Change

N/A

7 Day Change

0.10%

1 Month Change

-0.20%

3 Month Change

-4.40%

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

HLS Shortsell

Frequently Asked Questions

The current share price of Healius Limited (HLS:ASX) is AU$1.32.
The 52-week high share price for Healius Limited (HLS:ASX) is AU$1.86.
The 52-week low share price for Healius Limited (HLS:ASX)? is AU$1.08.
The current TTM dividend payout for Healius Limited (HLS:ASX) is 0.10.
The last dividend payment of Healius Limited (HLS:ASX) is AU$0.06.
Healius Limited (HLS:ASX) has a franking level of 100.0%.
Healius Limited (HLS:ASX) is classified in the Healthcare.
The current P/E ratio for Healius Limited (HLS:ASX) is 0.00.
logo
Login
Company
Company
Important

Get the latest insights and hot tips delivered right to your inbox

App Store Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.